UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer

Molecules (Basel, Switzerland), 2023-03, Vol.28 (7), p.3147

2023

Volltextzugriff (PDF)

Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy

Journal of nanobiotechnology, 2021-05, Vol.19 (1), p.138-23, Article 138

2021

Volltextzugriff (PDF)

EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy

Materials today advances, 2023-06, Vol.18, p.100375, Article 100375

2023

Volltextzugriff (PDF)

Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents

Journal of medicinal chemistry, 2023-03, Vol.66 (5), p.3393-3410

2023

Volltextzugriff (PDF)

Multi-specific niflumic acid platinum() complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage

Dalton transactions : an international journal of inorganic chemistry, 2022-12, Vol.52 (1), p.147-158

2022

Volltextzugriff (PDF)

Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL

Journal of controlled release, 2016-04, Vol.228, p.96-106

2016

Volltextzugriff (PDF)

Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy

Journal of controlled release, 2023-08, Vol.360, p.858-871

2023

Volltextzugriff (PDF)

Her3-specific affibody mediated tumor targeting delivery of ICG enhanced the photothermal therapy against Her3-positive tumors

International journal of pharmaceutics, 2022-04, Vol.617, p.121609-121609, Article 121609

2022

Volltextzugriff (PDF)

Modulation of pericytes by a fusion protein comprising of a PDGFRβ-antagonistic affibody and TNFα induces tumor vessel normalization and improves chemotherapy

Journal of controlled release, 2019-05, Vol.302, p.63-78

2019

Volltextzugriff (PDF)

Fusion of an EGFR-antagonistic affibody enhances the anti-tumor effect of TRAIL to EGFR positive tumors

International journal of pharmaceutics, 2022-05, Vol.620, p.121746-121746, Article 121746

2022

Volltextzugriff (PDF)

Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors

Molecular pharmaceutics, 2023-06, Vol.20 (6), p.2864-2875

2023

Volltextzugriff (PDF)

Coupling EGFR-Antagonistic Affibody Enhanced Therapeutic Effects of Cisplatin Liposomes in EGFR-expressing Tumor Models

Journal of pharmaceutical sciences, 2022-02, Vol.111 (2), p.450-457

2022

Volltextzugriff (PDF)

Increasing the antitumor efficacy of doxorubicin liposomes with coupling an anti-EGFR affibody in EGFR-expressing tumor models

International journal of pharmaceutics, 2020-08, Vol.586, p.119541, Article 119541

2020

Volltextzugriff (PDF)

ICG-Dimeric Her2-Specific Affibody Conjugates for Tumor Imaging and Photothermal Therapy for Her2-Positive Tumors

Molecular pharmaceutics, 2023-01, Vol.20 (1), p.427-437

2023

Volltextzugriff (PDF)

ICG-labeled PD-L1-antagonistic affibody dimer for tumor imaging and enhancement of tumor photothermal-immunotherapy

International journal of biological macromolecules, 2024-06, Vol.269 (Pt 2), p.132058-132058, Article 132058

2024

Volltextzugriff (PDF)

Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes

Pharmaceutical development and technology, 2024, Vol.29 (1), p.52-61

2024

Volltextzugriff (PDF)

Enhancing the circulating half-life and the antitumor effects of a tumor-selective cytotoxic peptide by exploiting endogenous serum albumin as a drug carrier

International journal of pharmaceutics, 2016-02, Vol.499 (1-2), p.195-204

2016

Volltextzugriff (PDF)

Preparation and characterization of a novel variant of human tumor necrosis factor-related apoptosis-inducing ligand from the rhesus monkey, Macaca mulatta

Applied microbiology and biotechnology, 2016-04, Vol.100 (7), p.3035-3047

2016

Volltextzugriff (PDF)

Conjugation to 10 kDa Linear PEG Extends Serum Half-Life and Preserves the Receptor-Binding Ability of mmTRAIL with Minimal Stimulation of PEG-Specific Antibodies

Molecular pharmaceutics, 2017-02, Vol.14 (2), p.502-512

2017

Volltextzugriff (PDF)

Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects

Theranostics, 2018-01, Vol.8 (9), p.2459-2476

2018

Volltextzugriff (PDF)

Production of bioactive, SUMO-modified, and native-like TNF-α of the rhesus monkey, Macaca mulatta, in Escherichia coli

Applied microbiology and biotechnology, 2012-03, Vol.93 (6), p.2345-2355

2012

Volltextzugriff (PDF)

Production of bioactive, SUMO-modified, and native-like TNF-[alpha] of the rhesus monkey, Macaca mulatta, in Escherichia coli

Applied microbiology and biotechnology, 2012-03, Vol.93 (6), p.2345

2012

Volltextzugriff (PDF)

Molecular cloning, recombinant expression and characterization of GMCSF from the rhesus monkey, Macaca mulatta

Developmental and comparative immunology, 2013-05, Vol.40 (1), p.69-77

2013

Volltextzugriff (PDF)

Comparative study on primary structure and function of rhesus monkey and human granulocyte macrophage colony stimulating factor

Frontiers in immunology, 2013, Vol.4

2013

Volltextzugriff (PDF)

Molecular Cloning, Recombinant Expression and Functional Characterization of the Soluble Tumor Necrosis Factor-related Apoptosis-inducing Ligand for the Macaca mulatta

Sheng wu yi xue gong cheng xue za zhi, 2015-06, Vol.32 (3), p.605

2015

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(48)
Tagungsberichte
(1)

Sprache

Englisch
(47)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(23)
Humans
(19)
Physical Sciences
(18)
Chemistry
(15)
Cell Line, Tumor
(14)
Pharmacology & Pharmacy
(13)
Animals
(12)
Mice
(10)
Affibody
(8)
Apoptosis
(7)
Chemistry, Multidisciplinary
(7)
Technology
(7)
Antineoplastic Agents - Pharmacology
(6)
Materials Science
(6)
Materials Science, Multidisciplinary
(5)
Cancer-Targeted Therapy
(4)
Chemistry, Physical
(4)
Chemotherapy
(4)
Egfr
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer

Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy

EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy

Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents

Multi-specific niflumic acid platinum() complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage

Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL

Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy

Her3-specific affibody mediated tumor targeting delivery of ICG enhanced the photothermal therapy against Her3-positive tumors

Modulation of pericytes by a fusion protein comprising of a PDGFRβ-antagonistic affibody and TNFα induces tumor vessel normalization and improves chemotherapy

Fusion of an EGFR-antagonistic affibody enhances the anti-tumor effect of TRAIL to EGFR positive tumors

Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors

Coupling EGFR-Antagonistic Affibody Enhanced Therapeutic Effects of Cisplatin Liposomes in EGFR-expressing Tumor Models

Increasing the antitumor efficacy of doxorubicin liposomes with coupling an anti-EGFR affibody in EGFR-expressing tumor models

ICG-Dimeric Her2-Specific Affibody Conjugates for Tumor Imaging and Photothermal Therapy for Her2-Positive Tumors

ICG-labeled PD-L1-antagonistic affibody dimer for tumor imaging and enhancement of tumor photothermal-immunotherapy

Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes

Enhancing the circulating half-life and the antitumor effects of a tumor-selective cytotoxic peptide by exploiting endogenous serum albumin as a drug carrier

Preparation and characterization of a novel variant of human tumor necrosis factor-related apoptosis-inducing ligand from the rhesus monkey, Macaca mulatta

Conjugation to 10 kDa Linear PEG Extends Serum Half-Life and Preserves the Receptor-Binding Ability of mmTRAIL with Minimal Stimulation of PEG-Specific Antibodies

Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects

Production of bioactive, SUMO-modified, and native-like TNF-α of the rhesus monkey, Macaca mulatta, in Escherichia coli

Production of bioactive, SUMO-modified, and native-like TNF-[alpha] of the rhesus monkey, Macaca mulatta, in Escherichia coli

Molecular cloning, recombinant expression and characterization of GMCSF from the rhesus monkey, Macaca mulatta

Comparative study on primary structure and function of rhesus monkey and human granulocyte macrophage colony stimulating factor

Molecular Cloning, Recombinant Expression and Functional Characterization of the Soluble Tumor Necrosis Factor-related Apoptosis-inducing Ligand for the Macaca mulatta

Suchergebnisse filtern